翻訳と辞書 ・ 2,6-Dihydroxypyridine ・ 2,6-dihydroxypyridine 3-monooxygenase ・ 2,6-Dimethoxybenzoquinone ・ 2,6-Dimethylnaphthalene ・ 2,6-Dimethylpiperidine ・ 2,6-dioxo-6-phenylhexa-3-enoate hydrolase ・ 2,6-Lutidine ・ 2,6-Naphthalenedicarboxylic acid ・ 2,6-Pyridinedicarbothioic acid ・ 2,6-Xylenol ・ 2,6-Xylidine ・ 2,7,4'-Trihydroxyisoflavanone 4'-O-methyltransferase ・ 2,7-Dihydrothiepine ・ 2,8-Dihydroxyadenine ・ 2,alpha-DMT ・ 2,N,N-TMT ・ 2- and 4-Quinolones ・ 2-(1,2-epoxy-1,2-dihydrophenyl)acetyl-CoA isomerase ・ 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a ・ 2-(2-Ethoxyethoxy)ethanol ・ 2-(2-Methoxyethoxy)ethanol ・ 2-(acetamidomethylene)succinate hydrolase ・ 2-(Dicyanomethylene)croconate ・ 2-(hydroxymethyl)-3-(acetamidomethylene)succinate hydrolase ・ 2-(R)-hydroxypropyl-CoM dehydrogenase ・ 2-(S)-hydroxypropyl-CoM dehydrogenase ・ 2-1-1 ・ 2-1-2 Forecheck ・ 2-10-0 ・ 2-10-10-2
|
|
2,N,N-TMT
2,''N,N''-Trimethyltryptamine, 2,''N,N''-TMT, or 2-Me-DMT is a tryptamine derivative that is a psychedelic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#34).〔(Erowid Online Books : "TIHKAL" - #34 2-ME-DMT )〕 It is claimed to show psychoactive effects at a dosage of 50–100 mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT2A receptor target that mediates the hallucinogenic effects of these drugs. ==See also==
* 5,N,N-TMT * 7,N,N-TMT
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「2,N,N-TMT」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|